Alteration of protein glycosylation in human hepatic stellate cells activated with transforming growth factor-β1.
Although aberrant glycosylation of human glycoproteins is related to liver fibrosis that results from chronic damage to the liver in conjunction with the activation of hepatic stellate cells (HSCs), little is known about the precision alteration of protein glycosylation referred to the activation of HSCs by transforming growth factor-β1 (TGF-β1). The human HSCs, LX-2 were activated by TGF-β1. The lectin microarrays were used to probe the alteration of protein glycosylation in the activated HSCs compared with the quiescent HSCs. Lectin histochemistry was used to further validate the lectin binding profiles and assess the distribution of glycosidic residues in cells. As a result, 14 lectins (e. g. AAL, PHA-E, ECA and ConA) showed increased signal while 7 lectins (e. g. UEA-I and GNA) showed decreased signal in the activated LX-2 compared with the quiescent LX-2. Meanwhile, AAL, PHA-E and ECA staining showed moderate binding to the cytoplasma membrane in the quiescent LX-2, and the binding intensified in the same regions of the activated LX-2. In conclusion, the precision alteration of protein glycosylation related to the activation of the HSCs may provide useful information to find new molecular mechanism of HSC activation and antifibrotic therapeutic strategies.
Laboratory for Functional Glycomics, College of Life Sciences, Northwest University, Xi'an 710069, China.
Yannan
Y
Qin
Yaogang
Y
Zhong
Liuyi
L
Dang
Minzhi
M
Zhu
Hanjie
H
Yu
Wentian
W
Chen
Jihong
J
Cui
Huijie
H
Bian
Zheng
Z
Li
D002460:Cell Line; D006031:Glycosylation; D055166:Hepatic Stellate Cells / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D037102:Lectins / Q000378:metabolism*; D040081:Protein Array Analysis; D053773:Transforming Growth Factor beta1 / Q000494:pharmacology*
D037102:Lectins; D053773:Transforming Growth Factor beta1